Netarsudil for open-angle glaucoma or ocular hypertension
NIHR HSRIC
Record ID 32016000644
English
Authors' objectives:
Glaucoma is a serious condition caused by abnormal pressure within the eye leading to blindness. All glaucoma treatments aim to prevent further damage to sight, but any damage to vision that has already been caused by glaucoma cannot be repaired. Glaucoma can be treated with eye drops, tablets, laser surgery, eye surgery or a combination of these methods.
Netarsudil is a new eye drop to treat patients with glaucoma. It works by reducing the pressure and increasing fluid removal from the eye to prevent further damage to the eye. Netarsudil is taken as an eye drop once a day.
If licensed for use in the UK, it could be a new treatment option for patients with glaucoma which works differently compared to other glaucoma eye drops.
Details
Project Status:
Completed
Year Published:
2016
URL for published report:
http://www.hsric.nihr.ac.uk/topics/netarsudil-for-open-angle-glaucoma-or-ocular-hypertension/
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Humans
- Glaucoma, Open-Angle
- Intraocular Pressure
- Ocular Hypertension
Contact
Organisation Name:
NIHR Horizon Scanning Centre
Contact Address:
The NIHR Horizon Scanning Centre, Department of Public Health, Epidemiology, and Biostatistics, School of Health and Population Sciences, University of Birmingham, 90 Vincent Drive, Edgbaston, Birmingham, B15 2SP. United Kingdom. Tel: +44 121 414 7831, Fax: +44 121 2269
Contact Name:
c.packer@bham.ac.uk
Contact Email:
c.packer@bham.ac.uk
Copyright:
NIHR Horizon Scanning Research&Intelligence Centre (NIHR HSRIC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.